东部肿瘤合作组 - 威斯康星州研究-猫眼课题宝

东部肿瘤合作组 - 威斯康星州研究

批准号：

7426841

负责人：

Brad Kahl

金额：

$61.06万

依托单位：

UNIVERSITY OF WISCONSIN-MADISON

依托单位国家：

美国

项目类别：

财政年份：

1978

资助国家：

美国

项目状态：

已结题

起止时间：

1978-06-01 至 2010-04-30

来源：

https://reporter.nih.gov/project-details/7426841

关键词：

Accountability Acute Myelocytic Leukemia Address Adenocarcinoma Adenovirus p53 Adherence Adjuvant Adjuvant Chemotherapy Adjuvant Therapy Adverse event Aesculus hippocastanum Affect African American Alaska Native Ambulatory Care Facilities American American Indian and Alaska Native American Indians American Society of Clinical Oncology Anthracycline Antibiotics Anthracyclines Antineoplastic Agents Applications Grants Appointment Area Arsenic trioxide/Ascorbic acid Art Therapy Arteries Asians Association of Community Cancer Centers Award Axillary lymph node group B-Lymphocytes Beds Behavior Berlin Bibliography Bilateral Biliary Biological Response Modifier Therapy Blast Phase Blood Blood Vessels Blood specimen Bone Density Bone Marrow Transplantation Brain Brain Neoplasms Breast Bronchoalveolar Lavage Calendar Cancer Burden Cancer Center Cancer Center Support Grant Cancer Control Cancer Model Cancer Patient Cancer Survivor Cancer Therapy Evaluation Program Candidate Disease Gene Caracemide Carboplatin Carboplatin/Paclitaxel Carboplatin/Paclitaxel/Thalidomide Carboxyamidotriazole Carcinoma Caring Carmustine Categories Cells Center Core Grants Cervix Uteri Cessation of life Chemoprevention Chemotherapy-Oncologic Procedure Chest Chronic Chronic Lymphocytic Leukemia Cisplatin Cisplatin/Paclitaxel Cities Cladribine Clinic Clinical Clinical Nursing Clinical Pharmacology Clinical Research Clinical Research Associate Clinical Treatment Clinical Trials Clinics and Hospitals Coffee Collaborations Colon Colon Carcinoma Colorectal Colorectal Cancer Commit Committee Members Communication Communities Community Clinical Oncology Program Community Health Centers Companions Complex Comprehensive Cancer Center Count Country County Critiques Cyclophosphamide Cyclophosphamide/Doxorubicin/Interferon Alfa/Prednisone/Vincristine DL-alpha-Difluoromethylornithine Dacarbazine Daily Data Data Collection Data Quality Databases Depth Development Developmental Therapeutics Program Diagnostic Diffuse Diffuse Large-Cell Lymphoma Discipline of Nursing Disease Disease remission Docetaxel/Gemcitabine Doctor of Pharmacy Doctor of Philosophy Documentation Dose Double-Blind Method Doxorubicin Drops Eastern Cooperative Oncology Group Echinomycin Economics Education Educational Curriculum Educational workshop Elderly Enrollment Ensure Epidermal Growth Factor Receptor Epithelial Esophageal Esophageal Adenocarcinoma Esophageal Squamous Cell Carcinoma Esophagectomy Esophagogastric Junction Esophagus Estramustine Ethnic Origin Ethnicity not Reported Etoposide Evaluation Evaluation Studies Excision Expressed Sequence Tags Extensive Stage Faculty Family Fatigue Fellowship Fellowship Program Female Financial compensation Floxuridine Fludarabine/Rituximab Fluorouracil Fluorouracil/Levamisole Flutamide Follicular Lymphoma Fostering Foundations Foxes Funding Future Gefitinib Gender Gene Therapy Agent Genes Genetic Variation Genets Genotype Genus Cola Germ cell tumor Glioblastoma Glioma Goals Grant Granulocyte-Macrophage Colony-Stimulating Factor Gray unit of radiation dose Group Meetings Group Structure Growth Gynecologic Head Head and Neck Cancer Head and neck structure Health Health Insurance Portability and Accountability Act Health behavior Health care facility Health system Heart Diseases Hematology Hematopathology Hepatic Hispanics Histopathologic Grade Hormones Hospital safety Hospitals Hour Housing Human Hypermethylation Illinois Image Immunotherapy Incidence Incidence Study Individual Indolent Industry Information Dissemination Infusion procedures Inpatients Institution Interferon Alfa-2a Interferon Alfa-2b Interferon-alpha Interferon-beta Interferons Interleukin-1 Interleukin-2 Internal Medicine Internet Intra-abdominal Investments Iowa Irrigation Islet Cell Islets of Langerhans Isotretinoin Joints Jordan Journals Kidney Kidney Failure Laboratories Laboratory Research Large Intestine Carcinoma Lead Leadership Learning Left Length Leucovorin Linear Accelerator Radiotherapy Systems Location Lomustine Lung Lung diseases Lymph node excision Lymphedema Lymphoma MGMT gene Maintenance Maintenance Therapy Malignant Epithelial Cell Malignant Neoplasms Malignant lymphoid neoplasm Malignant neoplasm of esophagus Malignant neoplasm of large intestine Malignant neoplasm of lung Malignant neoplasm of ovary Malignant neoplasm of pancreas Malignant neoplasm of prostate Mantle Cell Lymphoma Manuscripts Maps Measures Medical Medical Oncologist Medical Oncology Medical center Medicine Melphalan Menogaril Mentors Meta-Analysis Metastatic Melanoma Metastatic Neoplasm to the Liver Metastatic Prostate Cancer Methotrexate Methylphenidate Michigan Minority Minority Groups Mitosis Modality Monitor Morphology Mucositis Multiple Myeloma Murine Monoclonal Antibody 2B8 Mutation Myelogenous N phosphonoacetyl L aspartate N(delta)-acetylornithine, -isomer N-dodecanoylglutamic acid, -isomer, sodium salt N-methylformamide NCI Center for Cancer Research NCI-Designated Cancer Center Names National Surgical Adjuvant Breast and Bowel Project Native Hawaiian or Other Pacific Islander Neck Negative Axillary Lymph Node Neoplasm Metastasis New Agents Newly Diagnosed Non-Hodgkin&apos s Lymphoma Non-Measurable Non-Small-Cell Lung Carcinoma None or Not Applicable Not Hispanic or Latino Notification Numbers Nurses Nursing Research Oncologist Oncology Group Ontology Operative Surgical Procedures Oral Orchiectomy Outcome Outpatients Ovarian Ovary Paclitaxel Pain Palliative Care Palliative Medicine Palliative Surgery Palmar-plantar erythrodysesthesia syndrome Pancreas Pancreatic carcinoma Paper Parkinson Disease Participant Pathologic Pathology Pathology, Other Patient Care Team Patients Pelvis Performance Personal Satisfaction Pharmaceutical Preparations Pharmacologic Substance Pharmacology Pharmacy facility Phase Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Physicians Pilot Projects Planet Mars Play Policies Policy Research Population Positioning Attribute Positive Lymph Node Postmenopause Postoperative Period Poxviridae Predisposition Preparation Prevention Prevention Research Principal Investigator Problem Solving Procarbazine Procedures Process Productivity Prognostic Factor Program Development Prospective Studies Prostate Prostate Cancer Prevention Trial Prostate carcinoma Prostatic Intraepithelial Neoplasias Protocols documentation Published Comment Publishing Purpose Pycnogenol Quality of life Quality-of-Life Assessment Race Radiation Radiation Oncology Radiation Therapy Oncology Group Radiation therapy Radical Prostatectomy Radiology Specialty Radiosurgery Radium Randomized Randomized Controlled Clinical Trials Range Rate Recording of previous events Recurrence Refractory Regulation Relapse Renal Cell Carcinoma Reporting Research Research Activity Research Ethics Committees Research Infrastructure Research Personnel Research Support Resected Residual state Resistance Resources Retirement Retrieval Review Committee Review Literature Risk Risk Factors Robin bird Role Ruta S Phase SDZ-PSC-833 SECTM1 gene Safety Salvage Therapy Sampling Schedule Science Scientist Screening procedure Seeds Selenium Semustine Services Siblings Side Signal Transduction Site Site Visit Social Security Number Societies Southwest Oncology Group Specific qualifier value Staging Standards of Weights and Measures Stomach Stomach Carcinoma Strategic Planning Stratification Streptozocin Structure Sulindac Sulfone Supratentorial Surgeon Suspension substance Suspensions Symptoms System TP53 gene Telephone Testing Text Thalidomide Therapeutic Therapeutic Studies Therapeutics Committee Therapy Clinical Trials Thoracic Oncology Time Title Today Topotecan Toxic effect Training Training Programs Transitional Cell Carcinoma Translating Transplantation Travel Treatment Protocols Tretinoin Trimetrexate Tumor Burden Tumor Debulking United States Food and Drug Administration United States National Institutes of Health Universities University Hospitals University of Wisconsin Comprehensive Cancer Center Update Upper arm Urology Urothelium VA-2 Vaccination Vaccines Veterans Vincristine Vinorelbine Visit Wages West Virginia Wisconsin Wolves Woman Wood material Work Y 90 Ibritumomab Tiuxetan Zoledronate abstracting alpha-difluoromethyl-DOPA, -isomer alpha-methylornithine dihydrochloride, -isomer anticancer research authority base cancer care cancer cell cancer research center director cancer therapy cancer type capecitabine case finding celecoxib chemotherapy cisplatin/etoposide protocol citrin clinically relevant college computerized concept cost cyclophosphamide/doxorubicin/lomustine protocol data management day design docetaxel driving force drug development experience falls flu follow-up gastrointestinal gemcitabine gene therapy homoharringtonine hormone therapy human prostaglandin D2 receptor human subject ilium improved innovation instructor interdisciplinary approach interest iodonitrotetrazolium irradiation leukemia lung Carcinoma lung small cell carcinoma male malignant breast neoplasm medical schools melanoma member men multidisciplinary neuropsychiatry novel novel strategies older patient oligodendroglioma oncology outreach program patient safety performance status 2 perilla alcohol pilot trial piritrexim posters preference probation professor prognostic programs prospective protocol development quality assurance repository research study response rituximab sex skills success symposium symptom management therapy development tool trafficking trial comparing tumor urinary urologic

项目摘要

项目成果

Brad Kahl的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

DESCRIPTION (provided by applicant): This application seeks support for the activities of the Eastern Cooperative Oncology Group (ECOG) at the University of Wisconsin Comprehensive Cancer Center (UWCCC) and affiliated institutions. The clinical programs of the UWCCC are designed to improve both the treatment and care of cancer patients as well as to reduce the burden of the cancer problem in general. Our long association with the Eastern Cooperative Oncology Group (ECOG) has been beneficial in enhancing these goals. UWCCC Investigators have a history of strong commitment to ECOG accrual as well as administrative and scientific leadership. UWCCC clinics are organized along disease specific lines with efforts to enhance the multidisciplinary approaches needed for today's optimal cancer care and clinical research. During the last grant cycle this approach has been strengthened with recruitment in Medical Oncology and Surgery, new clinic space and enhancement of computerized research database facilities. All of this has improved our ECOG effort as manifested by consistent high accrual and group leadership activities. UW investigators chair the GU and Thoracic committees and co-chair the Pharmacology committee. UW investigators will lead chemoprevention efforts in ECOG. Institutional evaluations consistently rank the UW ECOG program at or near the top in categories of accrual, administrative and scientific leadership. UW ECOG affiliates continue to contribute with significant accrual and high quality data management and rank among the best in ECOG. ECOG studies and a clinical trials approach in cancer care are essential for continued high quality in the cancer programs at UW and throughout the region. ECOG studies serve as a core curriculum for trainees in Hematology and Medical and Radiation Oncology and as a basis for clinical strategies. The ECOG program remains an important component of the UWCCC cancer research effort and UWCCC contributions to ECOG remain equally important to the Group.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文